Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 138 publications
Targeting SIK2 with GRN-300 Potentiates Paclitaxel Efficacy in Triple-Negative Breast Cancer.
Journal: Cancers
Published: April 27, 2026
GlycoKnow Ovarian: a Glycoprotein-based, Serum Diagnostic to Distinguish Ovarian Cancers from Benign Pelvic Masses.
Journal: medRxiv : the preprint server for health sciences
Published: July 15, 2025
Quantitative proteomics identifies conserved proteins and altered regulation of mucin-16 in low grade serous ovarian cancers.
Journal: Clinical proteomics
Published: April 15, 2025
DIRAS3-derived cyclic peptides disrupt KRAS-RAF interaction and KRAS nanoclustering, suppressing KRAS-driven pancreatic and ovarian tumors.
Journal: iScience
Published: January 21, 2025
CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical Validation.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 08, 2024
A metabolite-based liquid biopsy for detection of ovarian cancer.
Journal: Biomarker research
Published: May 16, 2024
Normal Risk Ovarian Screening Study: 21-Year Update.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 09, 2024
A novel SIK2 inhibitor SIC-19 exhibits synthetic lethality with PARP inhibitors in ovarian cancer.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: October 20, 2023
IL-2-free tumor-infiltrating lymphocyte therapy with PD-1 blockade demonstrates potent efficacy in advanced gynecologic cancer.
Journal: BMC medicine
Published: October 03, 2023
Last Updated: 09/26/2026